1. Home
  2. HG vs FOLD Comparison

HG vs FOLD Comparison

Compare HG & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HG
  • FOLD
  • Stock Information
  • Founded
  • HG 2013
  • FOLD 2002
  • Country
  • HG Bermuda
  • FOLD United States
  • Employees
  • HG N/A
  • FOLD N/A
  • Industry
  • HG
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HG
  • FOLD Health Care
  • Exchange
  • HG Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • HG 2.4B
  • FOLD 2.5B
  • IPO Year
  • HG 2023
  • FOLD 2007
  • Fundamental
  • Price
  • HG $23.41
  • FOLD $8.12
  • Analyst Decision
  • HG Buy
  • FOLD Buy
  • Analyst Count
  • HG 7
  • FOLD 9
  • Target Price
  • HG $25.71
  • FOLD $28.00
  • AVG Volume (30 Days)
  • HG 486.2K
  • FOLD 3.4M
  • Earning Date
  • HG 11-05-2025
  • FOLD 11-05-2025
  • Dividend Yield
  • HG N/A
  • FOLD N/A
  • EPS Growth
  • HG N/A
  • FOLD N/A
  • EPS
  • HG 3.61
  • FOLD N/A
  • Revenue
  • HG $2,599,247,000.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • HG $18.17
  • FOLD $20.98
  • Revenue Next Year
  • HG $8.74
  • FOLD $20.74
  • P/E Ratio
  • HG $6.69
  • FOLD N/A
  • Revenue Growth
  • HG 21.31
  • FOLD 25.35
  • 52 Week Low
  • HG $16.80
  • FOLD $5.51
  • 52 Week High
  • HG $24.67
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • HG 48.88
  • FOLD 66.24
  • Support Level
  • HG $23.29
  • FOLD $7.79
  • Resistance Level
  • HG $24.48
  • FOLD $8.11
  • Average True Range (ATR)
  • HG 0.55
  • FOLD 0.28
  • MACD
  • HG -0.12
  • FOLD -0.03
  • Stochastic Oscillator
  • HG 11.59
  • FOLD 79.43

About HG Hamilton Insurance Group Ltd. Class B

Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: